(19)
(11) EP 1 159 297 A2

(12)

(88) Date of publication A3:
21.12.2000

(43) Date of publication:
05.12.2001 Bulletin 2001/49

(21) Application number: 00904245.8

(22) Date of filing: 07.01.2000
(51) International Patent Classification (IPC)7C07K 14/16, C07K 16/10, G01N 33/53, A61K 39/21, A61P 31/18, C12N 15/48, C12N 15/73
(86) International application number:
PCT/US0000/372
(87) International publication number:
WO 0042/068 (20.07.2000 Gazette 2000/29)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 11.01.1999 US 115430 P
06.05.1999 US 132760 P

(71) Applicant: THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Bethesda, MD 20892-9902 (US)

(72) Inventors:
  • SCALA, Giuseppe,National Institutes of Health
    Bethesda, MD 20892 (US)
  • CHEN, Xueni,National Institutes of Health
    Bethesda, MD 20892 (US)
  • COHEN, Oren, J.,National Institutes of Health
    Bethesda, MD 20892 (US)
  • FAUCI Anthony,.,National Institutes of Health
    Bethesda, MD 20892 (US)

(74) Representative: Heusch, Christian 
OK pat AGPatente Marken LizenzenChamerstrasse 50
6300 Zug
6300 Zug (CH)

   


(54) HIV RELATED PEPTIDES